These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21740739)

  • 1. Evaluation of etiological characteristics of Chinese women with recurrent spontaneous abortions: a single-centre study.
    Meng LL; Chen H; Tan JP; Wang ZH; Zhang R; Fu S; Zhang JP
    Chin Med J (Engl); 2011 May; 124(9):1310-5. PubMed ID: 21740739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses.
    Jaslow CR; Carney JL; Kutteh WH
    Fertil Steril; 2010 Mar; 93(4):1234-43. PubMed ID: 19338986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent pregnancy loss evaluation combined with 24-chromosome microarray of miscarriage tissue provides a probable or definite cause of pregnancy loss in over 90% of patients.
    Popescu F; Jaslow CR; Kutteh WH
    Hum Reprod; 2018 Apr; 33(4):579-587. PubMed ID: 29538673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based care of recurrent miscarriage.
    Porter TF; Scott JR
    Best Pract Res Clin Obstet Gynaecol; 2005 Feb; 19(1):85-101. PubMed ID: 15749068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss.
    Gürbüz B; Yalti S; Ozden S; Ficicioglu C
    Arch Gynecol Obstet; 2004 Jul; 270(1):37-9. PubMed ID: 12756582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two vs. three or more primary recurrent pregnancy losses--are there any differences in epidemiologic characteristics and index pregnancy outcome?
    Bashiri A; Ratzon R; Amar S; Serjienko R; Mazor M; Shoham-Vardi I
    J Perinat Med; 2012 Feb; 40(4):365-71. PubMed ID: 22752766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological characteristics of nonpregnant women with unexplained recurrent spontaneous abortion who underwent paternal lymphocytes immunization.
    Malinowski A; Wilczynski J; Zeman K; Glowacka E; Kolasa D; Szpakowski A; Oszukowski P; Szpakowski M
    Zentralbl Gynakol; 1998; 120(10):493-502. PubMed ID: 9823650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent first trimester pregnancy loss: revised definitions and novel causes.
    Allison JL; Schust DJ
    Curr Opin Endocrinol Diabetes Obes; 2009 Dec; 16(6):446-50. PubMed ID: 19779333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based investigations and treatments of recurrent pregnancy loss.
    Christiansen OB; Nybo Andersen AM; Bosch E; Daya S; Delves PJ; Hviid TV; Kutteh WH; Laird SM; Li TC; van der Ven K
    Fertil Steril; 2005 Apr; 83(4):821-39. PubMed ID: 15820784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent pregnancy loss: the key potential mechanisms.
    Baek KH; Lee EJ; Kim YS
    Trends Mol Med; 2007 Jul; 13(7):310-7. PubMed ID: 17574920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined thrombophilic factors among women with late recurrent spontaneous abortions].
    Ivanov P; Komsa-Penkova R; Konova E; Gecheva S; Ivanov I; Kovacheva K; Simeonova M; Tanchev S
    Akush Ginekol (Sofiia); 2011; 50(3):8-12. PubMed ID: 21916309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion.
    Pandey MK; Agrawal S
    Int Immunopharmacol; 2004 Feb; 4(2):289-98. PubMed ID: 14996420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of uterine defects in habitual abortion patients attended on at a university health service in Brazil.
    Guimarães Filho HA; Mattar R; Pires CR; Araujo Júnior E; Moron AF; Nardozza LM
    Arch Gynecol Obstet; 2006 Oct; 274(6):345-8. PubMed ID: 16947058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrent pregnancy loss--evaluation and treatment].
    Bashiri A; Gete S; Mazor M; Gete M
    Harefuah; 2011 Nov; 150(11):852-6, 875. PubMed ID: 22428207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ITI-H4, as a biomarker in the serum of recurrent pregnancy loss (RPL) patients.
    Kim MS; Gu BH; Song S; Choi BC; Cha DH; Baek KH
    Mol Biosyst; 2011 May; 7(5):1430-40. PubMed ID: 21331437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiological profile of Omani women with recurrent pregnancy loss.
    Eltayeb SM; Ambusaidi SK; Gowri V; Alghafri WM
    Saudi Med J; 2014 Jul; 35(7):757-60. PubMed ID: 25028238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune causes of recurrent pregnancy loss.
    Festin MR; Limson GM; Maruo T
    Kobe J Med Sci; 1997 Oct; 43(5):143-57. PubMed ID: 9642970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent pregnancy loss: summary and clinical recommendations.
    Lee RM; Silver RM
    Semin Reprod Med; 2000; 18(4):433-40. PubMed ID: 11355802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective study of couples with a history of recurrent spontaneous abortion.
    Maione S; Lamberti L; Alovisi C; Armellino F
    Acta Eur Fertil; 1995; 26(3):95-100. PubMed ID: 9098467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.
    Bu C; Zhang C; Li Z; Gao L; Xie Z; Cai G
    Clin Exp Immunol; 2007 Jul; 149(1):31-9. PubMed ID: 17425656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.